Article info
PDFBenefits to nonparticipants
Paper
The morality of risks in research: reflections on Kumar
- Correspondence to Professor F M Kamm, Harvard Kennedy School, 79 JFK Street, Cambridge MA 02138, USA; frances_kamm{at}harvard.edu
Citation
The morality of risks in research: reflections on Kumar
Publication history
- Received February 2, 2016
- Accepted February 16, 2016
- First published September 19, 2016.
Online issue publication
January 25, 2017
Article Versions
- Previous version (25 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Limits to research risks
- Must research benefit human subjects if it is to be permissible?
- Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio
- Risk, double effect and the social benefit requirement
- Stem cell stories: from bedside to bench
- Refuting the net risks test: a response to Wendler and Miller’s “Assessing research risks systematically”
- The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens
- ‘In a twilight world’? Judging the value of life for the minimally conscious patient
- How to keep high-risk studies ethical: classifying candidate solutions
- Payment in challenge studies: ethics, attitudes and a new payment for risk model